• 1
    Thornton JG, Lilford RJ. Do we need randomised trials of antenatal tests of fetal wellbeing?. Br J Obstet Gynaecol 1993;100: 197200.
  • 2
    Neilson JP, Alfirevic Z. Doppler ultrasound for fetal assessment in high risk pregnancies [Cochrane review]. The Cochrane Library, Issue 2. Oxford : Update Software, 2002.
  • 3
    Veen S, Ens-Dokkum MH, Schreuder AM, Verloove-Vanhorick SP, Brand R, Ruys JH. Impairments disabilities and handicaps of very pre-term and very-low-birthweight infants at five years of age. Lancet 1991;338: 3336.
  • 4
    Karsdorp VHM, van Vugt JMG, van Geijn HP, et al. Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery. Lancet 1994;344: 16641668.
  • 5
    Visser GHA, Stigter RH, Bruinse HW. Management of the growth retarded fetus. Eur J Obstet Gynecol Reprod Biol 1991;42: S73S78.
  • 6
    Fetal Compromise GroupFormal measurement of clinical uncertainty: prelude to a trial in perinatal medicine. BMJ 1994;308: 111112.
  • 7
    Gaudier FL, Goldenberger RL, Nelson KG, et al. Acid base status and subsequent neurosensory impairment in surviving 500 to 1000 gm infants. Am J Obstet Gynecol 1994;170: 4853.
  • 8
    The GRIT Study GroupWhen do obstetricians recommend delivery for a high-risk preterm growth-retarded fetus?. Eur J Obstet Gynecol Reprod Biol 1996;67: 121126.
  • 9
    Hornbuckle J, Thornton JG, Kelly M, Welch CR, Oldham J, GRIT study group Patient randomisation on the web. BMJ 1997;314: 1604.
  • 10
    Hanson R, Aldridge Smith J. Achievements of young children on items of the Griffiths scales: 1980 compared with 1960. Child: Care, Health and Development 1987;13: 181195.
  • 11
    Spiegelhalter D, Freedman LS, Parmar MKB. Bayesian approaches to randomised controlled trials. J R Stat Soc 1994;157: 357416.
  • 12
    Parmar MKB, Griffiths GO, Spiegelhalter DJ, Souhami RL, Altman DG, van der Scheuren E. Monitoring large randomised clinical trials—a new approach using Bayesian methods. Lancet 2001;358: 375381.
  • 13
    Vail A, Hornbuckle J, Spiegelhalter DJ, Thornton JG. Prospective application of Bayesian monitoring and analysis in an ‘open’ randomised clinical trial. Stat Med. 2001: 37773787.
  • 14
    Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe pre-eclampsia at 28 to 32 weeks gestation: a randomized controlled trial. Am J Obstet Gynecol 1994;171: 818822.
  • 15
    Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze JT. Aggressive or expectant management for patients with severe preeclampsia between 28–34 weeks' gestation: a randomized controlled trial. Obstet Gynaecol 1990;76: 10701075.
  • 16
    Schaap AH, Wolf H, Bruinse HW, de Leeuw R, van Ertbruggen I, Treffers PE. Fetal distress due to placental insufficiency at 26 through 31 weeks: a comparison between an active and a more conservative management. Eur J Obstet Gynecol Reprod Biol 1996;70(1):6168 December.
  • 17
    Harrington K, Carpenter RG, Nguyen M, Campbell S. Changes observed in Doppler studies of the fetal circulation in pregnancies complicated by pre-eclampsia or the delivery of a small-for-gestational-age baby. I. Cross-sectional analysis. Ultrasound Obstet Gynecol 1995;6(1):1928.
  • 18
    Kurmanavicius J, Florio I, Wisser J, et al. Reference resistance indices of the umbilical, fetal middle cerebral and uterine arteries at 24–42 weeks of gestation. Ultrasound Obstet Gynecol 1997;10: 112120.